References
- Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266–270.
- Song YX, Huang XZ, Gao P, et al. Clinicopathologic and prognostic value of serum carbohydrate antigen 19-9 in gastric cancer: a meta-analysis. Dis Markers. 2015;2015:1.
- Lumachi F, Marino F, Orlando R, et al. Multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. Anticancer Res. 2012;32:985–988.
- Canney PA, Wilkinson PM, James RD, et al. CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125. Br J Cancer. 1985;52:131.
- Assmar M, Yeganeh S, Mansourghanaei F, et al. Combined evaluation of AFP, CA15-3, CA125, CA19-9, and CEA tumor markers in patients with hepatitis B and C. Iran J Public Health. 2016;45:1645–1651.
- Ong SL, Sachdeva A, Garcea G, et al. Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration. Dig Dis Sci. 2008;53:3213–3217.
- Giannini E, Borro P, Botta F, et al. Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis. Int J Biol Markers. 2000;15:226–230.
- Fukasawa H, Kaneko M, Niwa H, et al. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease. Nephrology (Carlton). 2018;23:210–216.
- Shang X, Song C, Du X, et al. The serum levels of tumor marker CA19-9, CEA, CA72-4, and NSE in type 2 diabetes without malignancy and the relations to the metabolic control. SMJ. 2017;38:204–208.
- Kurdoglu Z, Gursoy R, Kurdoglu M, et al. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis. Fertil Steril. 2009;92:1761–1763.
- Nagata H, Takahashi K, Yamane Y, et al. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. Gynecol Obstet Invest. 1989;28:165–168.
- Pyeon SY, Park JY, Ki KD, Lee JM. Abnormally high level of CA-19-9 in a benign ovarian cyst. Obstet Gynecol Sci. 2015;58:530–532.
- Thomsen LH, Schnack TH, Buchardi K, et al. Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review. Acta Obstet Gynecol Scand. 2017;96:761–778.
- Al-Janabi AA, Tawfeeq EF. Interfering Effect of Black Tea Consumption on Diagnosis of Pancreatic Cancer by CA 19-9. J Gastrointest Cancer. 2017;48:148–150.
- Howaizi M, Abboura M, Krespine C, et al. A new cause for CA19.9 elevation: heavy tea consumption. Gut. 2003;52:913–914.